Skip to main content

Table 2 Summary of the best estimates and 95% confidence intervals of the parameters of the three examined normal tissue complication probability models for four acute bladder symptoms, respectively

From: Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy

Lyman-Kutcher-Burman (LKB) model

Symptom

Vref

D50 (Gy)

m

n

 Urinary urgency

Whole

64.2 (54.6–78.7)

0.50 (0.35–0.88)

1.00 (0.40–7.00)

 Urinary incontinence

Whole

95.0 (77.2–130.6)

0.45 (0.35–0.62)

0.50 (0.13–3.51)

 Frequency

150cm3

83.1 (61.3–132.9)

0.56 (0.43–0.81)

1.00 (0.55–7.00)

 Nocturia

150cm3

85.4 (63.0–143.1)

0.60 (0.47–0.87)

1.00 (0.40–7.00)

Logit model

Symptom

Vref

D50 (Gy)

k

n

 Urinary urgency

Whole

67.6 (60.0–77.7)

3.04 (1.67–4.63)

0.49 (0.20–3.44)

 Urinary incontinence

Whole

96.7 (85.8–107.6)

4.55 (3.19–5.92)

0.01 (0.01–0.07)

 Frequency

150cm3

117.2 (82.0–183.1)

1.35 (0.95–1.86)

1.00 (0.40–7.00)

 Nocturia

150cm3

123.1 (81.6–197.0)

1.23 (0.86–1.69)

1.00 (0.40–7.00)

Relative Seriality model

Symptom

Vref

D50 (Gy)

γ

s

 Urinary urgency

Whole

68.5 (55.6–86.4)

0.51 (0.28–0.74)

10−4 (10−5-7 × 10−4)

 Urinary incontinence

Whole

103.1 (83.8–138.0)

0.59 (0.41–0.81)

0.85 (0.08–5.92)

 Frequency

150cm3

134.7 (84.2–336.7)

0.33 (0.18–0.48)

0.82 (0.33–5.73)

 Nocturia

150cm3

119.5 (74.7–280.9)

0.34 (0.18–0.49)

0.73 (0.29–5.12)

  1. Responders are considered the patients with ≥2 levels of increase from baseline in the patient reported toxicity scale